Cargando…
Targeting Metabolic Reprogramming of T-Cells for Enhanced Anti-Tumor Response
Cancer immunotherapy is an effective treatment option against cancer. One of the approaches of cancer immunotherapy is the modification of T cell-based anti-tumor immune responses. T-cells, a type of adaptive immune response cells responsible for cell-mediated immunity, have long been recognized as...
Autores principales: | Dabi, Yosef Tsegaye, Andualem, Henok, Degechisa, Sisay Teka, Gizaw, Solomon Tebeje |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113448/ https://www.ncbi.nlm.nih.gov/pubmed/35592358 http://dx.doi.org/10.2147/BTT.S365490 |
Ejemplares similares
-
The mitochondrial associated endoplasmic reticulum membranes: A platform for the pathogenesis of inflammation‐mediated metabolic diseases
por: Degechisa, Sisay T., et al.
Publicado: (2022) -
Genome Editing and Human Pluripotent Stem Cell Technologies for in vitro Monogenic Diabetes Modeling
por: Dabi, Yosef Tsegaye, et al.
Publicado: (2022) -
Leptin Deficiency May Influence the Divergence of Cell-Mediated Immunity Between Lepromatous and Tuberculoid Leprosy Patients
por: Degechisa, Sisay Teka, et al.
Publicado: (2022) -
Changes in plasma levels of endocrine hormones in lepromatous leprosy patients
por: Dabi, Yosef Tsegaye, et al.
Publicado: (2022) -
Toll‐like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential
por: Dabi, Yosef Tsegaye, et al.
Publicado: (2023)